LIPO GANTRISIN
LOE ApproachingNDAORALEMULSION
Approved
Dec 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LIPO GANTRISIN is a sulfisoxazole oral emulsion approved by Roche in 1953 for bacterial infections. The exact indications are not fully documented in available data, but sulfisoxazole is a sulfonamide antibiotic used primarily for urinary tract and other bacterial infections. This small-molecule formulation represents a legacy antibiotic product with decades of clinical use.
LOE Approaching
This legacy antibiotic is approaching loss of exclusivity with minimal commercial momentum; teams are typically small and focused on maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on LIPO GANTRISIN offers limited career growth; the product is in maintenance mode with negligible linked job opportunities. This role is suitable only for professionals seeking stable, low-complexity positions in legacy antibiotic management rather than career advancement.
Brand Manager (Legacy Products)Field Sales Representative
Worked on LIPO GANTRISIN at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.